Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Life & Style 'Bánh tro' is believed to bring good luck and good health to locals at Đoan Ngọ Festival